Mood disorders (MD), including depression a bipolar disorders, are the most common psychiatric comorbidities among patients with substance abuse (SA) disorders. Treating patientsAi co-occurring MD may reduce their substance craving a enhance their overall outcomes. A staged screening a assessment can ease the diagnostic challenge of distinguishing symptoms of affective MD from manifestations of SA intoxication a withdrawal. Treatment should maximize the use of psychotherapeutic interventions a give first consideration to medications proven effective in the context of co-occurring SA. Expanded commun. a collab. between SA a mental health providers is crucial to improving outcomes for patients with these difficult disorders. IllusA code that is not identified as either a#39;a#39;censusa#39;a#39; or a#39;a#39;FIPSa#39;a#39; is usually a census code for which there is no FIPS equivalent, or for which the Census Bureau does not use the FIPS code. The exceptions, which use only the FIPS code in censusanbsp;...
|Title||:||Mood Disorders and Substance Use Disorder: A Complex Comorbidity|
|Author||:||Susan B. Quello|
|Publisher||:||DIANE Publishing - 2008-05|